Literature DB >> 15084330

Spectrophotometric and electrochemical determination of the formation constants of the complexes Curcumin-Fe(III)-water and Curcumin-Fe(II)-water.

Marganta Bernabé-Pineda1, Maria Teresa Ramírez-Silva, Mario Alberto Romero-Romo, Enrique González-Vergara, Alberto Rojas-Hernández.   

Abstract

The formation of complexes among the Curcumin, Fe(III) and Fe(II) was studied in aqueous media within the 5-11 pH range by means of UV-Vis spectrophotometry and cyclic voltammetry. When the reaction between the Curcumin and the ions present in basic media took place, the resulting spectra of the systems Curcumin-Fe(III) and Curcumin-Fe(II) presented a similar behaviour. The cyclic voltammograms in basic media indicated that a chemical reaction has taken place between the Curcumin and Fe(III) before that of the formation of complexes. Data processing with SQUAD permitted to calculate the formation constants of the complexes Curcumin-Fe(III), corresponding to the species FeCur (lob beta110 = 22.25 +/- 0.03) and FeCur(OH)- (log beta111 = 12.14 +/- 0.03), while for the complexes Curcumin-Fe(II) the corresponding formation constants of the species FeCur- (log beta110 = 9.20 +/- 0.04), FeHCur (log beta111 = 19.76 +/- 0.03), FeH2Cur+ (log beta112 = 28.11 +/- 0.02). Copyright 2003 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084330     DOI: 10.1016/S1386-1425(03)00344-5

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  20 in total

Review 1.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

2.  β-dicarbonyl enolates: a new class of neuroprotectants.

Authors:  Richard M LoPachin; Terrence Gavin; Brian C Geohagen; Lihai Zhang; Diana Casper; Rukmani Lekhraj; David S Barber
Journal:  J Neurochem       Date:  2010-12-02       Impact factor: 5.372

3.  Curcumin inhibits growth of Saccharomyces cerevisiae through iron chelation.

Authors:  Steven Minear; Allyson F O'Donnell; Anna Ballew; Guri Giaever; Corey Nislow; Tim Stearns; Martha S Cyert
Journal:  Eukaryot Cell       Date:  2011-09-09

4.  Curcumin and Turmeric Modulate the Tumor-Promoting Effects of Iron In Vitro.

Authors:  Donald J Messner; Todd Robinson; Kris V Kowdley
Journal:  Nutr Cancer       Date:  2017-01-27       Impact factor: 2.900

5.  Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator.

Authors:  Yan Jiao; John Wilkinson; Xiumin Di; Wei Wang; Heather Hatcher; Nancy D Kock; Ralph D'Agostino; Mary Ann Knovich; Frank M Torti; Suzy V Torti
Journal:  Blood       Date:  2008-09-24       Impact factor: 22.113

6.  Curcumin reduces the toxic effects of iron loading in rat liver epithelial cells.

Authors:  Donald J Messner; Gowsala Sivam; Kris V Kowdley
Journal:  Liver Int       Date:  2008-05-19       Impact factor: 5.828

7.  Enolate-Forming Phloretin Pharmacophores: Hepatoprotection in an Experimental Model of Drug-Induced Toxicity.

Authors:  Brian C Geohagen; Amaresh Vydyanathan; Boleslav Kosharskyy; Naum Shaparin; Terrence Gavin; Richard M LoPachin
Journal:  J Pharmacol Exp Ther       Date:  2016-03-30       Impact factor: 4.030

Review 8.  Antioxidants in liver health.

Authors:  Sael Casas-Grajales; Pablo Muriel
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

Review 9.  Curcumin: from ancient medicine to current clinical trials.

Authors:  H Hatcher; R Planalp; J Cho; F M Torti; S V Torti
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.